BNP Paribas Financial Markets’s Allena Pharmaceuticals ALNA Stock Holding History

BNP Paribas Financial Markets’s Portfolio ALNA Stock Details ALNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-62	Closed	-$98	–	4324
2020 Q2	$98	Hold	62	–	–	﹤0.01%	4219
2020 Q1	$60	Hold	62	–	–	﹤0.01%	4235
2019 Q4	$169	Sell	62 -1,297	-95%	-$4.26K	﹤0.01%	4314
2019 Q3	$5.35K	Hold	1,359	–	–	﹤0.01%	4260
2019 Q2	$5.53K	Sell	1,359 -1,116	-45%	-$6.1K	﹤0.01%	4229
2019 Q1	$17.4K	Buy	2,475 +2,451	+10,213%	+$17.8K	﹤0.01%	3933
2018 Q4	$131	Sell	24 -174	-88%	-$1.5K	﹤0.01%	4152
2018 Q3	$2.13K	Sell	198 -27	-12%	-$297	﹤0.01%	4251
2018 Q2	$2.93K	Sell	225 -700	-76%	-$10.1K	﹤0.01%	4208
2018 Q1	$10.2K	Sell	925 -115	-11%	-$961	﹤0.01%	4013
2017 Q4	$10.5K	Buy	+1,040	New	+$12.8K	﹤0.01%	4026

Other funds holding ALNA

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

TGI

TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BNP Paribas Financial Markets's ALNA Position: Q3 2020 in Review

BNP Paribas Financial Markets sold out of Allena Pharmaceuticals (ALNA) in Q3 2020, closing a stake of 62 shares — an estimated $98 sold.

BNP Paribas Financial Markets first reported a position in ALNA in Q4 2017 and held it in 11 quarters. The position peaked at $17.4K in Q1 2019. 24 funds tracked by Wall St. Rank hold ALNA as of Q3 2020.

BNP Paribas Financial Markets reported no remaining Allena Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
BNP Paribas Financial Markets sold 62 Allena Pharmaceuticals shares in Q3 2020, an estimated $98.
BNP Paribas Financial Markets first reported a position in Allena Pharmaceuticals in Q4 2017 and held it in 11 quarters.
BNP Paribas Financial Markets's Allena Pharmaceuticals position peaked at $17.4K in Q1 2019.
24 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q3 2020.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2020, filed 30 Oct 2020.